Cargando…

Cellular Basis of Organotin(IV) Derivatives as Anticancer Metallodrugs: A Review

Organotin(IV) compounds have wide applications in industrial and agricultural fields owing to their ability to act as poly(vinyl chloride) stabilizers and catalytic agents as well as their medicinal properties. Moreover, organotin(IV) compounds may have applications as antitumor, anti-inflammatory,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syed Annuar, Sharifah Nadhira, Kamaludin, Nurul Farahana, Awang, Normah, Chan, Kok Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342812/ https://www.ncbi.nlm.nih.gov/pubmed/34368075 http://dx.doi.org/10.3389/fchem.2021.657599

Ejemplares similares

Organotin (IV) Dithiocarbamate Compounds as Anticancer Agents: A Review of Syntheses and Cytotoxicity Studies
por: Abd Aziz, Nurul Amalina, et al.
Publicado: (2023)

Synthesis and cytotoxic activity of organotin(IV) diallyldithiocarbamate compounds as anticancer agent towards colon adenocarcinoma cells (HT-29)
por: Haezam, Farah Natasha, et al.
Publicado: (2021)

Series of Organotin(IV) Compounds with Different Dithiocarbamate Ligands Induced Cytotoxicity, Apoptosis and Cell Cycle Arrest on Jurkat E6.1, T Acute Lymphoblastic Leukemia Cells
por: Rasli, Nur Rasyiqin, et al.
Publicado: (2023)

Crystal structures and Hirshfeld surface analyses of (N-hexyl-N-methyldithiocarbamato-κ(2) S,S′)triphenyltin(IV) and [N-methyl-N-(2-phenylethyl)dithiocarbamato-κ(2) S,S′]triphenyltin(IV)
por: Mohamad, Rapidah, et al.
Publicado: (2018)

(N-Ethyl-N-phenyldithiocarbamato-κS)triphenyltin(IV)
por: Kamaludin, Nurul Farahana, et al.
Publicado: (2011)

(N-Butyl-N-phenyldithiocarbamato-κS)triphenyltin(IV)
por: Kamaludin, Nurul Farahana, et al.
Publicado: (2011)

[N-Benzyl-N-(2-phenylethyl)dithiocarbamato-κ(2) S,S′]triphenyltin(IV) and [bis(2-methoxyethyl)dithiocarbamato-κ(2) S,S′]triphenyltin(IV): crystal structures and Hirshfeld surface analysis
por: Mohamad, Rapidah, et al.
Publicado: (2016)

Crystal structures and Hirshfeld surface analyses of bis[N,N-bis(2-methoxyethyl)dithiocarbamato-κ(2) S,S′]di-n-butyltin(IV) and [N-(2-methoxyethyl)-N-methyldithiocarbamato-κ(2) S,S′]triphenyltin(IV)
por: Mohamad, Rapidah, et al.
Publicado: (2018)

Di-n-butylbis(N-ethyl-N-phenyldithiocarbamato-κS)tin(IV)
por: Kamaludin, Nurul Farahana, et al.
Publicado: (2011)

(N,N-Diallyldithiocarbamato-κ(2) S,S′)triphenyltin(IV) and bis(N,N-diallyldithiocarbamato-κ(2) S,S′)diphenyltin(IV): crystal structure, Hirshfeld surface analysis and computational study
por: Haezam, Farah Natasha, et al.
Publicado: (2020)

(N,N-Diisopropyldithiocarbamato)triphenyltin(IV): crystal structure, Hirshfeld surface analysis and computational study
por: Haezam, Farah Natasha, et al.
Publicado: (2019)

Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug
por: Ugalde-Arbizu, Maider, et al.
Publicado: (2023)

Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer
por: Ovejero Paredes, Karina, et al.
Publicado: (2020)

Di-n-butylbis[N-(2-methoxyethyl)-N-methyldithiocarbamato-κ(2) S,S′]tin(IV): crystal structure and Hirshfeld surface analysis
por: Mohamad, Rapidah, et al.
Publicado: (2017)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

NMR studies of group 8 metallodrugs: (187)Os-enriched organo-osmium half-sandwich anticancer complex
por: Needham, Russell J., et al.
Publicado: (2021)

Molecular methods for assessment of non-covalent metallodrug–DNA interactions
por: Kellett, Andrew, et al.
Publicado: (2019)

A nitrogen-base catalyzed generation of organotin(ii) hydride from an organotin trihydride under reductive dihydrogen elimination
por: Sindlinger, Christian P., et al.
Publicado: (2015)

Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential
por: Azmatullah, Syed, et al.
Publicado: (2022)

Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes
por: Abás, Elisa, et al.
Publicado: (2021)

Potent anticancer activity of a novel iridium metallodrug via oncosis
por: Ortega-Forte, Enrique, et al.
Publicado: (2022)

Synthesis and Antifungal Activity of Some Organotin(IV) Carboxylates
por: Bonire, Josiah J., et al.
Publicado: (1998)

Organotin(IV) Dithiocarbamate Complexes: Chemistry and Biological Activity
por: Adeyemi, Jerry O., et al.
Publicado: (2018)

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
por: Su, Yan, et al.
Publicado: (2022)

Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
por: Spreckelmeyer, Sarah, et al.
Publicado: (2014)

Biologically potent organotin(iv) complexes of N-acetylated β-amino acids with spectroscopic, X-ray powder diffraction and molecular docking studies
por: Riaz, Nagina Naveed, et al.
Publicado: (2023)

Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles
por: Qiao, Hongzhi, et al.
Publicado: (2021)

Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey
por: Tolbatov, Iogann, et al.
Publicado: (2021)

Influence of coordinating groups of organotin compounds on the Fries rearrangement of diphenyl carbonate
por: Liu, Tao, et al.
Publicado: (2019)

Target-directed catalytic metallodrugs
por: Joyner, J.C., et al.
Publicado: (2013)

Organotin(IV) Derivatives of L-Cysteine and their in vitro Anti-Tumor Properties
por: Chasapis, Christos T., et al.
Publicado: (2004)

Nanoparticles of novel organotin(IV) complexes bearing phosphoric triamide ligands
por: Shariatinia, Zahra, et al.
Publicado: (2013)

Photostabilization of Poly(vinyl chloride) by Organotin(IV) Compounds against Photodegradation
por: Hadi, Angham G., et al.
Publicado: (2019)

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
por: Harada, Shusaku, et al.
Publicado: (2015)

Rapid screening of photoactivatable metallodrugs: photonic crystal fibre microflow reactor coupled to ESI mass spectrometry
por: McQuitty, Ruth J., et al.
Publicado: (2017)

Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures
por: Galé, Audrey, et al.
Publicado: (2021)

Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug
por: Miller, Maya, et al.
Publicado: (2020)

Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer
por: Sánchez-Lara, Eduardo, et al.
Publicado: (2018)

Using bio-orthogonally catalyzed lethality strategy to generate mitochondria-targeting anti-tumor metallodrugs in vitro and in vivo
por: Xue, Xuling, et al.
Publicado: (2020)

Synthesis of Organotin Polyamine Ethers Containing Acyclovir and their Preliminary Anticancer and Antiviral Activity
por: Carraher, Charles E., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3kk9m1da431d105v947i4ugo7s